NOVABRIDGE BIOSCIENCES (NBP) Forecast, Price Target & Analyst Ratings

NASDAQ:NBP • US44975P1030

Current stock price

2.4 USD
+0.04 (+1.69%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NOVABRIDGE BIOSCIENCES (NBP).

Forecast Snapshot

Consensus Price Target

Price Target
$8.57
+ 257.00% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2025
EPS Estimate
-$0.06
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.44%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.57
Upside
+ 257.00%
From current price of $2.40 to mean target of $8.57, Based on 9 analyst forecasts
Low
$7.07
Median
$9.18
High
$9.45

Price Target Revisions

1 Month
0.00%
3 Months
0.80%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for NBP. The average price target is 8.57 USD. This implies a price increase of 257% is expected in the next year compared to the current price of 2.4.
The average price target has been revised upward by 0.8% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NBP Current Analyst RatingNBP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

NBP Historical Analyst RatingsNBP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
84.44%
NBP was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NBP.
In the previous month the buy percentage consensus was at a similar level.
NBP was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-08HC Wainwright & Co.Reiterate Buy -> Buy
2026-03-16HC Wainwright & Co.Reiterate Buy -> Buy
2026-02-06HC Wainwright & Co.Maintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2025
EPS Estimate
-$0.06
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
30.56%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
NBP revenue by date.NBP revenue by date.
88M
-94.30%		-221.6M
-351.82%		632K
100.29%
-100.00%		2.949M28.331M
860.70%		122.36M
331.89%		105M
-14.19%		194.93M
85.65%		252.97M
29.77%
EBITDA
YoY % growth
NBP ebitda by date.NBP ebitda by date.
-2.057B
-1,310.54%		-1.943B
5.51%		-48.501M
97.50%		-1.351B
-5.49%		-159.165M
-211.08%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
NBP ebit by date.NBP ebit by date.
-2.071B
-1,431.17%		-1.97B
4.91%		-48.976M
97.51%		-60.968M
-5.00%		-38.337M
25.45%		-45.393M
-18.41%		-58.82M
-29.58%		-72.521M
-23.29%		-64.574M
10.96%		51.505M
179.76%		34.737M
-32.56%		104.33M
200.34%		133.04M
27.52%
Operating Margin
NBP operating margin by date.NBP operating margin by date.
-2,353.75%888.76%-7,749.37%N/AN/AN/AN/A-2,459.18%-227.93%42.09%33.08%53.52%52.59%
EPS
YoY % growth
NBP eps by date.NBP eps by date.
N/A
-345.78%		N/A
-18.84%		N/A
3.71%		-0.13
40.52%		-0.10
89.90%		-0.32
-216.67%		-0.43
-35.79%		-0.38
12.40%		-0.43
-14.15%		0.27
161.63%		0.23
-13.21%		0.67
186.96%		0.84
25.76%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.06
30.56%		-0.03
-1.00%		-0.04
38.79%		-0.04
-34.67%		-0.04
27.27%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-8.133M
37.44%		-8.364M
-58.83%		-9.2M
-29.32%		-10.12M
-12.58%		-11.132M
-36.88%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NBP Yearly Revenue VS EstimatesNBP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2028 2029 2030 2031 2032 2033 0 500M 1B 1.5B
NBP Yearly EPS VS EstimatesNBP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.5 -0.5 -1 -1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
16.12%
EPS Next 5 Year
9.38%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NOVABRIDGE BIOSCIENCES / NBP Forecast FAQ

Can you provide the average price target for NOVABRIDGE BIOSCIENCES stock?

9 analysts have analysed NBP and the average price target is 8.57 USD. This implies a price increase of 257% is expected in the next year compared to the current price of 2.4.

What are the consensus estimates for NBP stock next earnings?

The consensus EPS estimate for the next earnings of NOVABRIDGE BIOSCIENCES (NBP) is -0.06 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for NOVABRIDGE BIOSCIENCES (NBP) stock?

The consensus rating for NOVABRIDGE BIOSCIENCES (NBP) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.